改良硼替佐米联合地塞米松治疗初发多发性骨髓瘤的疗效及安全性(6)
[25] Bensinger WI，Jagannath S，Vescio R，et al. Phase 2 study of two sequential three-drug containing bortezomib，cyctlophosphamide and dexamethasone，followed by bortezomib，thalidomide and dexamethasone as frontline therapy for multiple myeloma[J]. Br J Haematol，2010， 148(4)：562-568.
[26] Hideshima T，Richardson P，Chauhan D，et al. The proteasome inhibitor PS-341 inhibits growth，induces apoptosis，and overcomes drug resistance in human multiple myeloma cells[J]. Cancer Res， 2001，61(7)：3071-3076.
[27] Jaqannath S，Barloqie B，Berenson J，et al. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma[J]. Br J Haematol，2004，127(2)：165-172.
[28] 鮑立，卢锡京，张晓晖，等.不同剂量硼替佐米联合地塞米松治疗难治复发多发性骨髓瘤[J]. 中华医学杂志，2008，88(26)：1829-1831.
[29] Yuan ZG，Jin J，Huang XJ，et al. Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma：An open-label，observational，multi-center study in China[J]. Chin Med J，2011，124(19)：2969-2974.
[30] 苏基滢，周立宇，徐黎，等.偏小剂量的硼替佐米联合地塞米松治疗初发多发性骨髓瘤疗效观察[J]. 癌症进展，2012，10(1)：80-83.
[31] Li J，Zhou DB，Jiao L，et al. Bortezomib and dexamethasone therapy for newly diagnosed patients with multiple myeloma complicated by renal impairment[J]. Clin Lymphoma Myeloma，2009，9(5)：394-398.
[32] 李娟，曾丽金，赵莹，等.硼替佐米联合地塞米松治疗初治多发性骨髓瘤[J]. 中华血液学杂志，2009，30(8)：543-547.
(收稿日期：2018-11-21), http://www.100md.com(翁翔 陈丽 章敬成 胡慧仙 朱逸霞)
[26] Hideshima T，Richardson P，Chauhan D，et al. The proteasome inhibitor PS-341 inhibits growth，induces apoptosis，and overcomes drug resistance in human multiple myeloma cells[J]. Cancer Res， 2001，61(7)：3071-3076.
[27] Jaqannath S，Barloqie B，Berenson J，et al. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma[J]. Br J Haematol，2004，127(2)：165-172.
[28] 鮑立，卢锡京，张晓晖，等.不同剂量硼替佐米联合地塞米松治疗难治复发多发性骨髓瘤[J]. 中华医学杂志，2008，88(26)：1829-1831.
[29] Yuan ZG，Jin J，Huang XJ，et al. Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma：An open-label，observational，multi-center study in China[J]. Chin Med J，2011，124(19)：2969-2974.
[30] 苏基滢，周立宇，徐黎，等.偏小剂量的硼替佐米联合地塞米松治疗初发多发性骨髓瘤疗效观察[J]. 癌症进展，2012，10(1)：80-83.
[31] Li J，Zhou DB，Jiao L，et al. Bortezomib and dexamethasone therapy for newly diagnosed patients with multiple myeloma complicated by renal impairment[J]. Clin Lymphoma Myeloma，2009，9(5)：394-398.
[32] 李娟，曾丽金，赵莹，等.硼替佐米联合地塞米松治疗初治多发性骨髓瘤[J]. 中华血液学杂志，2009，30(8)：543-547.
(收稿日期：2018-11-21), http://www.100md.com(翁翔 陈丽 章敬成 胡慧仙 朱逸霞)